Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8700
0.00 (0.00%)
At close: Jun 3, 2026
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €767.35 thousand as of June 3, 2026. Its market cap has decreased by -10.71% in one year.
Market Cap
767.35K
Enterprise Value
11.73M
Revenue
24.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 767.35K, a decrease of -98.52%. That is a compound annual growth rate of -30.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 762.97K | -3.33% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.85B |
| Siemens Healthineers AG | 37.98B |
| Bayer Aktiengesellschaft | 33.50B |
| Fresenius SE & Co. KGaA | 20.53B |
| aap Implantate AG | 27.40M |
| NanoRepro AG | 22.70M |
| Maternus-Kliniken Aktiengesellschaft | 21.39M |
| Biofrontera AG | 15.37M |